Janus Henderson Investors
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Tenpoint Therapeutics
29 Jan 2026
Tenpoint Therapeutics unlocks a £170m Series B from investors to rejuvenate vision in the aging eye
Tenpoint Therapeutics develops treatments for age-related eye conditions. Its products are designed to address presbyopia and other vision issues through clinically developed ophthalmic therapies.
Artios
18 Nov 2025
Artios Pharma lands £90m Series D led by SV Health Investors and RA Capital Management to advance DNA damage response therapeutics
Artios Pharma develops cancer treatments that target DNA damage response pathways, focusing on patient groups with limited existing treatment options.
Janus Henderson Investors
More venture news
- 3 Jun 2026
Wordsmith AIWordsmith raises £55m Series B from Highland Europe and Index Ventures to bring end-to-end operations platform to in-house legal teams
Series BLegal - 28 May 2026
Orbital IndustriesOrbital Industries lands £37m Series B led by Plural to build data centre hardware with AI model
Series BAI - 20 May 2026
RemotePassRemotePass unlocks £13m Series B led by EBRD VC for cross-border payroll and workforce management platform
Series BEnterprise
